INPIXON INPX Income Statement

Inpixon (INPX)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Products
-	-	-	-	-	-	-	-	-	-	52	12,210	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Services
-	-	-	-	-	-	-	-	-	-	819	2,886	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Products
-	-	-	-	-	-	-	-	-	-	-	-	9,448	9,639	8,366	9,157	10,348	16,745	10,706	13,542	10,388	11,837	10,957	14,025	13,225	-	-	-	-
Services
-	-	-	-	-	-	-	-	-	-	-	-	4,033	4,869	2,874	4,175	3,739	3,519	4,168	4,155	3,734	3,365	3,326	3,119	3,095	-	-	-	-
Revenues
1,804	1,913	1,534	1,491	1,363	1,128	940	839	849	-25,513	871	15,096	13,481	14,508	11,240	13,332	14,087	20,264	14,874	17,697	14,122	15,202	14,283	17,144	16,320	16,480	13,941	14,788	5,361
Products
-	-	-	-	-	-	-	-	-	-	94	10,231	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Services
-	-	-	-	-	-	-	-	-	-	173	1,481	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Products
-	-	-	-	-	-	-	-	-	-	-	-	8,054	6,662	6,873	7,448	8,042	13,163	8,601	10,349	8,650	9,531	8,620	10,047	10,708	-	-	-	-
Services
-	-	-	-	-	-	-	-	-	-	-	-	2,139	3,408	1,269	2,440	2,098	1,903	1,885	1,652	1,425	1,235	1,388	1,418	1,262	-	-	-	-
Cost of Revenues
510	499	382	391	337	257	298	256	265	-20,940	267	11,712	10,193	10,070	8,142	9,888	10,140	15,066	10,486	12,001	10,075	10,766	10,008	11,465	11,970	12,462	10,159	11,789	3,905
Gross Profit
1,294	1,414	1,152	1,100	1,026	871	642	583	584	-4,573	604	3,384	3,288	4,438	3,098	3,444	3,947	5,198	4,388	5,696	4,047	4,436	4,275	5,679	4,350	4,018	3,782	2,999	1,455
Operating Expenses
Research and development
1,334	1,215	926	796	956	411	296	253	271	-272	224	454	558	566	587	537	587	14	207	251	163	247	206	163	0	-	-	-	-
Sales and marketing
691	882	847	681	633	467	447	479	333	-2,295	441	2,181	2,040	1,787	1,876	2,336	2,501	3,300	2,693	3,075	2,463	2,578	2,568	2,523	2,297	-	-	-	-
General and administrative
3,791	3,770	3,521	3,018	3,351	5,353	2,326	3,530	2,940	-1,618	3,239	4,595	4,658	4,153	3,699	3,452	3,965	4,457	3,542	2,953	3,274	3,077	3,519	3,024	2,315	-	-	-	-
Compensation and related benefits
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,015	2,772	1,982	1,088
Professional fees and consulting expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	397	831	423	47
Consulting expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	225	68
Occupancy
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	150	126	103	36
Acquisition related costs
28	57	573	510	137	14	78	0	16	0	0	2	3	824	22	10	20	154	13	112	76	-179	0	1,091	104	589	316	0	907
Impairment of goodwill
-	-	-	-	-	-	-	-	-	-	587	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Costs associated with public offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	356	187	0	0
Amortization of intangibles
1,016	1,028	969	820	812	812	812	804	804	-637	808	1,382	1,383	1,159	1,056	1,057	1,056	1,056	1,056	1,000	882	893	443	1,249	328	329	236	193	62
Other administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	985	326	500	205
Total Operating Expenses
6,860	6,952	6,836	5,825	5,889	7,693	3,959	5,066	4,364	-4,822	5,299	8,614	8,642	15,889	7,240	7,392	8,129	8,981	7,511	7,391	6,858	6,616	6,736	8,050	5,044	5,529	4,794	3,429	2,417
Loss from Operations
-5,566	-5,538	-5,684	-4,725	-4,863	-6,822	-3,317	-4,483	-3,780	249	-4,695	-5,230	-5,354	-11,451	-4,142	-3,948	-4,182	-3,783	-3,123	-1,695	-2,811	-2,180	-2,461	-2,371	-694	-1,511	-1,012	-430	-962
Other Income (Expense)
Interest expense, net
-621	-222	-1,190	-509	-356	-261	-78	-80	-822	396	-252	-1,344	-684	-706	-639	-255	-143	-108	-120	-121	-99	-80	-95	-104	-108	-	-76	-	-
Loss on exchange of debt for equity
-86	-	-27	-160	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	58	27
Interest expense - amortization of debt discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	16
Gain (Loss) on the settlement of obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	140	-14	-
Change in fair value of shares to be issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	-1	-	69	89	0	-	-	-	-	0	0	0	-489
Change in fair value of derivative liability
-	-	-	-	-	0	0	0	48	301	46	152	56	10	41	0	0	-	0	-	-	-	-	-	-	-	-	-	-
Gain on the sale of Sysorex Arabia
-	-	-	-	-	0	0	0	23	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on the settlement of obligations
-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19	20	-	2	32	5	14	7	12	14	18	12	0	0
Change in fair value of shares to be issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-
Other income/(expense)
18	-1,079	289	163	69	-200	-1	-9	-1	-1,018	14	0	-65	-2,686	15	-227	-124	168	-49	0	-94	328	-88	-92	-94	-117	76	-43	-533
Change in fair value of shares to be issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Other Income (Expense)
-689	-12,035	-928	-506	-287	-462	-78	-89	-752	-974	-192	-1,192	-693	-	-578	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss from Operations, before tax
-6,255	-	-6,612	-	-5,150	-	-3,395	-	-	-	-	-	-	-	-	-	-	-	-	-1,695	-2,905	-1,852	-2,549	-2,463	-788	-1,629	-936	-474	-1,495
Income tax benefit
-87	-	-33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-35	0	0	35	0	0	0	0
Net Loss from Continuing Operations
-	-	-6,579	-5,231	-	-7,284	-3,395	-4,572	-4,532	-725	-4,887	-6,422	-6,047	-13,544	-4,720	-4,175	-4,306	-	-	-	-	-	-	-	-	-	-	-	-
Loss from Discontinued Operations, Net of Tax
-	-	-	-	-	1	-1,785	-1,283	-1,711	-7,177	-9,754	-9	-9	-758	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss
-6,168	-17,022	-6,579	-5,231	-5,150	-7,283	-5,180	-5,855	-6,243	-7,902	-14,641	-6,431	-6,056	-14,302	-4,720	-4,175	-4,306	-3,957	-3,172	-1,695	-2,905	-1,817	-2,549	-2,463	-823	-1,629	-936	-474	-1,495
Net Loss Attributable to Non-controlling Interest
-10	0	5	9	-5	-	4	3	-	-5	-4	-4	-4	-377	-4	-4	-4	-3	-4	2	-5	-11	-6	-56	-43	-167	-29	-38	-37
Net Loss Attributable to Stockholders of Inpixon
-6,158	-17,022	-6,584	-5,240	-5,145	-7,287	-5,184	-5,858	-6,243	-7,897	-14,637	-6,427	-6,052	-13,925	-4,716	-4,171	-4,302	-3,954	-3,168	-1,697	-2,900	-1,806	-2,543	-2,407	-780	-1,461	-907	-435	-1,458
Deemed dividend to preferred stockholders
-	-	-	-	-	4,828	0	-9,727	-1,508	-756	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend for triggering of warrant down round feature
-	0	0	0	-1,250	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss Attributable to Common Stockholders
-6,158	-17,022	-6,584	-5,240	-6,395	-16,104	-5,184	-15,585	-7,751	-8,653	-14,637	-6,427	-6,052	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss Per Basic and Diluted Common Share
Loss from continuing operations
-	-	-0.28	-0.56	-	-2,222.07	-3.17	-39.49	-57.57	-2,117.06	-620.65	-81.20	-83.56	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-256.95	-1.67	-3.54	-16.31	-1,372.57	-1,238.76	-0.11	-0.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss Per Share - Basic and Diluted
-1.22	17.34	-0.28	-0.57	-64.01	-2,479.00	-4.84	-43.05	-73.88	-3,487.61	-1,858.90	-81.26	-83.63	-382.05	-81.15	-2.49	-2.57	-248.57	-0.16	-0.09	-0.15	-0.11	-0.13	-0.13	-0.05	-0.09	-0.07	-0.03	-0.16
Weighted Average Shares Outstanding
Basic and Diluted
5,038	-29,758	23,366	9,257	99	-1,469	1,071	362	104	-72,425	7	79	72,364	-3,117,423	58	1,675,267	1,673,714	-59,217	19,833	19,806	19,765	19,934	19,624	18,641	14,244	14,162	13,064	12,552	9,372
Net Loss
-6,168	-17,022	-6,579	-5,231	-5,150	-7,283	-5,180	-5,855	-6,243	-7,902	-14,641	-6,431	-6,056	-	-4,720	-4,175	-	-	-	-	-	-	-	-	-	-1,629	-936	-474	-1,495
Unrealized foreign exchange gain/(loss) from cumulative translation adjustments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Unrealized holding gains in marketable securities including reclassification adjustment of realized gains included in net income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Comprehensive Loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-936	-	-